Mainz Biomed B.V. MYNZ
3.59 USD 0.00 (+0.00%)
May 22, 2026, 12:35 PM EDT
3.38 Day range 3.72
52-week range unavailable
- YTD
- +220.54%
- 1 year
- +41.34%
Analyst view
Price target (mean) —
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 2
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current year | -23.60 | -23.60 – -23.60 | -64.80 | +63.6% | 1.07M | +19.6% | 1 |
| Next year | -9.20 | -9.20 – -9.20 | -23.60 | +61.0% | 1.40M | +30.7% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 25, 2024 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Apr 12, 2024 | Cantor Fitzgerald | Reiterated | — | Neutral |
| Mar 6, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 21, 2023 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Nov 20, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 26, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Sep 22, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 14, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 22, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 18, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 1, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| May 18, 2023 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Apr 27, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 30, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 16, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 10, 2023 | JonesTrading | Initiated | — | Buy |
| Oct 25, 2022 | Cantor Fitzgerald | Initiated | — | Overweight |
| Jun 21, 2022 | HC Wainwright & Co. | Initiated | — | Buy |